Austrian breast cancer screening a success:
This article was originally published in Clinica
The steady fall in the number of women dying from breast cancer in Austria over the past 10 years is a result of effective early detection and improved therapy, says the Vienna regional sickness fund (WGKK). Vienna introduced screening of women between the ages of 50-70 under the auspices of the WGKK, the Viennese doctors' chamber and the Vienna council, in 2001. The screening added to earlier measures that saw the three-year survival rate, which was some 15% in the 1970s, reach 61% by the end of the 1990's, it claims. The five-year rate has also risen from 10-40% over the same period. 18 Viennese women contract breast cancer and eight die from the disease per week, on average.
You may also be interested in...
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.